findmyKOL

Michael Basha, DO

Basic profile

Henry Ford Health System

ORCIDNone on fileNPI
RegionPort Huron, MI · MidwestSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1998Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Basha is a Respiratory physician affiliated with Henry Ford Health System. OpenAlex indexes 11 publications with 561 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
11publications

Distinct works indexed by OpenAlex.

561citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
16companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1231 Pine Grove Avenue
Suite 2b
Port Huron, MI 480603500

Telephone

810-987-5500

Registry record last updated 20 Dec 2018.

View the NPPES registry record

Industry payments

16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    61.7%
    Corticosteroid30.9%
    Trelegy Ellipta47%Symbicort17%Breo Ellipta16%Budesonide-Formoterol Fumarate10%Breztri Aerosphere5%Fluticasone Propionate2%Breyna2%Dulera1%Qvar Redihaler1%
    Part D<11 patients
    beta2-Adrenergic Agonist16.6%
    Albuterol Sulfate Hfa77%Ventolin Hfa23%
    Part D192 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    13.7%
    Corticosteroid10.2%
    Prednisone100%
    Part D221 patients
    Proton pump inhibitor2.1%
    Pantoprazole Sodium53%Omeprazole34%Esomeprazole Magnesium13%
    Part D<11 patients

    + 3 more classes in this area

  • Cardiovascular

    8.3%
    Statin2.4%
    Atorvastatin Calcium56%Rosuvastatin Calcium29%Simvastatin15%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)1.6%
    Losartan Potassium67%Olmesartan-Hydrochlorothiazide19%Losartan-Hydrochlorothiazide14%
    Part D<11 patients

    + 7 more classes in this area

Where care is delivered (Part B)84.6% facility · 15.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”